Trial Profile
Phase III clinical trial of transdermal ropinirole (HP 3000) in patients with idiopathic restless legs syndrome.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2015
Price :
$35
*
At a glance
- Drugs Ropinirole (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 04 Feb 2015 New trial record